Factors | Multivariate Analysis | ||
---|---|---|---|
HR | 95% CI | P | |
Male | 1.364 | 0.613–3.035 | 0.447 |
TACE + sorafenib versus sorafenib | 0.461 | 0.273–0.780 | 0.004 |
Age | 0.995 | 0.976–1.014 | 0.581 |
Tumor number | 1.140 | 0.936–1.389 | 0.193 |
Tumor diameter (cm) | 1.038 | 0.969–1.111 | 0.288 |
No vascular invasion | 0.557 | 0.314–0.988 | 0.045 |
Metastasis | 1.334 | 0.834–2.133 | 0.229 |
Child-Pugh stage A | 0.991 | 0.484–2.030 | 0.980 |
AFP < 400 ng/mL | 0.695 | 0.437–1.106 | 0.125 |